Nanotechnology in vaccine delivery

Martin J. D’souza; Suprita A. Tawde; Archana Akalkotkar; Lipika Chablani; Marissa D’souza; Maurizio Chiriva-Internati

doi:10.1007/978-3-319-00978-0_19

Nanotechnology in vaccine delivery

Martin J. D’souza, Suprita A. Tawde, Archana Akalkotkar, Lipika Chablani, Marissa D’souza, Maurizio Chiriva-Internati

Research output: Chapter in Book/Report/Conference proceeding › Chapter

3 Scopus citations

Abstract

Immunotherapy has been a trusted therapy for centuries to eliminate infectious diseases. However, the successful immunotherapy depends on several factors such as nature of pathogen, vaccine delivery system, route of administration, and immune system of the host. With the advances in nanotechnology, immunotherapy is now targeting different challenging disorders including cancer as well as infectious diseases. Along with the evolution of several adjuvants to enhance immune response to vaccines, nanotechnology plays an important role by acting as self-adjuvant in form of particles.

Original language	English (US)
Title of host publication	Molecular Vaccines
Subtitle of host publication	From Prophylaxis to Therapy - Volume 2
Publisher	Springer International Publishing
Pages	727-741
Number of pages	15
ISBN (Electronic)	9783319009780
ISBN (Print)	9783319009773
DOIs	https://doi.org/10.1007/978-3-319-00978-0_19
State	Published - Jan 1 2014
Externally published	Yes

ASJC Scopus subject areas

General Medicine
General Immunology and Microbiology

Access to Document

10.1007/978-3-319-00978-0_19

Cite this

@inbook{d2ba027148ab4e79b8795c7d0559ed3f,

title = "Nanotechnology in vaccine delivery",

abstract = "Immunotherapy has been a trusted therapy for centuries to eliminate infectious diseases. However, the successful immunotherapy depends on several factors such as nature of pathogen, vaccine delivery system, route of administration, and immune system of the host. With the advances in nanotechnology, immunotherapy is now targeting different challenging disorders including cancer as well as infectious diseases. Along with the evolution of several adjuvants to enhance immune response to vaccines, nanotechnology plays an important role by acting as self-adjuvant in form of particles.",

author = "D{\textquoteright}souza, {Martin J.} and Tawde, {Suprita A.} and Archana Akalkotkar and Lipika Chablani and Marissa D{\textquoteright}souza and Maurizio Chiriva-Internati",

year = "2014",

month = jan,

day = "1",

doi = "10.1007/978-3-319-00978-0_19",

language = "English (US)",

isbn = "9783319009773",

pages = "727--741",

booktitle = "Molecular Vaccines",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Nanotechnology in vaccine delivery

AU - D’souza, Martin J.

AU - Tawde, Suprita A.

AU - Akalkotkar, Archana

AU - Chablani, Lipika

AU - D’souza, Marissa

AU - Chiriva-Internati, Maurizio

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Immunotherapy has been a trusted therapy for centuries to eliminate infectious diseases. However, the successful immunotherapy depends on several factors such as nature of pathogen, vaccine delivery system, route of administration, and immune system of the host. With the advances in nanotechnology, immunotherapy is now targeting different challenging disorders including cancer as well as infectious diseases. Along with the evolution of several adjuvants to enhance immune response to vaccines, nanotechnology plays an important role by acting as self-adjuvant in form of particles.

AB - Immunotherapy has been a trusted therapy for centuries to eliminate infectious diseases. However, the successful immunotherapy depends on several factors such as nature of pathogen, vaccine delivery system, route of administration, and immune system of the host. With the advances in nanotechnology, immunotherapy is now targeting different challenging disorders including cancer as well as infectious diseases. Along with the evolution of several adjuvants to enhance immune response to vaccines, nanotechnology plays an important role by acting as self-adjuvant in form of particles.

UR - http://www.scopus.com/inward/record.url?scp=84957685676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957685676&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-00978-0_19

DO - 10.1007/978-3-319-00978-0_19

M3 - Chapter

AN - SCOPUS:84957685676

SN - 9783319009773

SP - 727

EP - 741

BT - Molecular Vaccines

PB - Springer International Publishing

ER -

Nanotechnology in vaccine delivery

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this